Literature DB >> 21686977

Unstable angina following intracavernous injection of alprostadil: a case study.

Nicolas Barry Delongchamps1, Guillaume Legrand, Marc Zerbib, Michael Peyromaure.   

Abstract

Intracavernous injection of alprostadil is the gold standard treatment for erectile dysfunction following radical prostatectomy. After surgery, low doses of alprostadil can be delivered for the sole purpose of penile rehabilitation. The only reported systemic side effects of such injections are arterial hypotension and headache. In the current report, a case of unstable angina immediately following an intracavernous injection of alprostadil is described.

Entities:  

Year:  2009        PMID： 21686977      PMCID： PMC3029550          DOI： 10.1136/bcr.03.2009.1658

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  5 in total

Review 1.  Clinical practice. Erectile dysfunction.

Authors:  Kevin T McVary
Journal:  N Engl J Med       Date:  2007-12-13       Impact factor: 91.245

2.  Erectile dysfunction and subsequent cardiovascular disease.

Authors:  Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

3.  Sex and death: are they related? Findings from the Caerphilly Cohort Study.

Authors:  G Davey Smith; S Frankel; J Yarnell
Journal:  BMJ       Date:  1997 Dec 20-27

4.  Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial.

Authors:  F Montorsi; G Guazzoni; L F Strambi; L F Da Pozzo; L Nava; L Barbieri; P Rigatti; G Pizzini; A Miani
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

Review 5.  Prostaglandin E1 for treatment of erectile dysfunction.

Authors:  R Urciuoli; T A Cantisani; M Carlini; M Giuglietti; F M Botti
Journal:  Cochrane Database Syst Rev       Date:  2004
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.